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OBJECTIVE — To determine whether elevated fasting or 2-h plasma glucose and/or insulin
better reﬂects the presence of cardiovascular disease (CVD) risk markers in an overweight
pediatric population with normal glucose tolerance.
RESEARCH DESIGN AND METHODS — A total of 151 overweight youths (8–17
yearsold)wereevaluatedwithoralglucosetolerancetestsandmeasurementofCVDriskfactors.
The study population was categorized according to quartiles of fasting and 2-h glucose and
insulin levels. ANCOVA, adjusted for age, sex, race, Tanner stage, and percent body fat (mea-
sured by dual-energy X-ray absorptiometry), was used to compare metabolic variables between
the quartiles of glucose and insulin groups.
RESULTS — Increasing quartiles of fasting and 2-h insulin were associated with increasing
CVD risk factors. Glucose quartiles on the other hand, either fasting or at 2 h, were not.
CONCLUSIONS — These data suggest that hyperinsulinemia may be the earliest and/or
primary metabolic alteration in childhood associated with risk markers for CVD. Prospective
studies are needed.
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T
he prevalence of childhood over-
weight is increasing relentlessly (1–
2). An increase in the rates of pre-
diabetes and type 2 diabetes seems to
follow the upward trend of obesity (3).
Longitudinal studies in adults demon-
strate that cardiovascular disease (CVD)
changesareestablishedbeforeadiagnosis
of diabetes is made and correlate better
with 2-h glucose levels (4–5). Guidelines
on diabetes and CVD from the European
Society of Cardiology and the European
AssociationfortheStudyofDiabeteshave
summarized that 2-h glucose provides
better information about risk for CVD
than fasting glucose and predicts in-
creased cardiovascular risk in subjects
with normal fasting glucose levels (6).
Meta-analyses of prospective data
from 11 populations have shown that hy-
perinsulinemia, deﬁned by the highest
quartile cutoff for fasting insulin, was as-
sociated with cardiovascular mortality in-
dependently of other risk factors (7). A
review of 19 Western prospective studies
showed that the odds ratio (OR) for cor-
onary heart disease for raised fasting in-
sulin as well as nonfasting insulin were
more modest than previously suspected
(OR 1.12 [95% CI 0.98–1.28] and 1.35
[1.14–1.60], respectively) (8).
No studies have evaluated whether a
fastingor2-hglucoseand/orinsulinvalue
reﬂects better the presence of CVD risk
factors in overweight children with nor-
mal glucose tolerance. The purpose of
this investigation was to assess the rela-
tionship between glucose and insulin
quartiles and CVD risk factors in an
overweight pediatric population.
RESEARCH DESIGN AND
METHODS — Overweight(BMI85th
percentile for age and sex) but otherwise
healthy youth, 71 African American and
80 Caucasian (aged 8–17 years), under-
went assessment of glucose tolerance at
the Pediatric Clinical and Translational
Research Center at Children’s Hospital of
Pittsburgh. Exclusion criteria and source
of recruitment have been previously de-
scribed (9). The investigation was ap-
proved by the Institutional Review Board
of the University of Pittsburgh. Parental
informed consent and child assent were
obtained. All participants underwent an
examinationwithheightandweightmea-
surements and BMI calculation. Body
composition was measured by dual-
energy X-ray absorptiometry (DEXA; Lu-
nar, Madison, WI).
Biochemical measurements
Plasma glucose, insulin, lipid proﬁle, adi-
ponectin, leptin, and the nontraditional
CVD risk markers intracellular adhesion
molecule-1, vascular cell adhesion mole-
cule-1, and E-selectin were measured as
described previously (9–11). Proinsulin,
ﬁbrinogen, and high-sensitivity C-reac-
tive protein (hs-CRP) were measured at
the Esoterix Endocrinology Laboratory
(Calabasas Hills, CA). For hs-CRP, values
10 mg/l were excluded because they
may be a sign of occult infection or other
systemicinﬂammatoryprocess(10of151
participants) (12).
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Data are presented as means  SD for
normally distributed continuous vari-
ables, median (interquartile range) for
non-normal continuous variables, and n
(%)forcategoricalvariables.Independent
Student t tests were used to compare nor-
mally distributed continuous subject
characteristics, and Pearson 
2 test was
used to compare proportions. The study
population was categorized according to
quartiles of fasting and 2-h glucose and
insulin levels to assess differences be-
tween the quartiles in CVD risk factors.
ANCOVA, adjusted for age, sex, race,
Tanner stage (prepubertal and pubertal),
and percent body fat (measured by
DEXA), was used to compare metabolic
variables between the quartiles of glucose
and insulin groups. Statistical analyses
were performed using SPSS 15.0 (SPSS,
Chicago,IL).Allstatisticaltestsweretwo-
tailed, and P values of 0.05 were con-
sidered to be statistically signiﬁcant.
RESULTS— Of the 151 subjects, 71
wereAfricanAmerican(59%female,41%
male; mean age 12.3  2 years; Tanner
stage22.9%prepubertal,77.1%pubertal;
meanBMI32.15.8kg/m
2;BMIpercen-
tile 98.2  2.0; percent body fat 43.2 
7.5%) and 80 were Caucasian (54% fe-
male, 46% male; mean age 13.1  2.6
years; Tanner stage 21.9% prepubertal,
78.8% pubertal; mean BMI 33.0  6.8
kg/m
2; BMI percentile 98.4.2  1.6; per-
cent body fat 43.8  6.1%).
Therewerenosigniﬁcantassociations
between quartiles of glucose levels, either
fasting (mean glucose 77  4, 85  1,
901,and942mg/dl,respectively,in
the lowest, 2nd, 3rd, and highest quar-
tiles) or at 2 h (mean glucose 94  7,
108  3, 118  3, and 129  4 mg/dl,
respectively, in the lowest, 2nd, 3rd, and
highest quartiles), with any of the CVD
risk factors (P for trend 0.05) after ad-
justing for age, sex, race, Tanner stage,
and percent body fat.
The median (interquartile range) val-
ues for fasting insulin levels was 13.7
(12.0–15.3), 21.0 (18.4–22.0), 28.7
(26.2–30.7), and 43.8 (37.8–53.7)
IU/mlforquartiles1,2,3,and4,respec-
tively. For 2-h insulin levels the values
were 48.1 (30.7–52.9), 76.4 (69.1–
84.2), 125.4 (107.0–155.4), and 222.8
(202.0–300.0) IU/ml for quartiles 1, 2,
3, and 4, respectively.
Quartilesofinsulin,fastingandat2h,
were associated with heightened CVD
risk factors. Figure 1 indicates CVD risk
factors that showed a statistically signiﬁ-
cant trend. Systolic and diastolic blood
pressure, triglycerides, VLDL cholesterol,
intracellular adhesion molecule-1, and
leptin increased signiﬁcantly with in-
creasing fasting insulin; triglycerides,
VLDL-cholesterol, and leptin increased
with increasing 2-h insulin. HDL choles-
terol decreased with increasing quartiles
of fasting insulin (44  12, 42  9, 40 
7, 39  9 mg/dl for quartiles 25, 25–
50, 50–75 and 75, respectively;
P for trend  0.04)
CONCLUSIONS — Our ﬁndings in
overweight nondiabetic children demon-
strate that 1) an increase in insulin quar-
tiles, fasting and at 2 h, was associated
with higher levels of a number of CVD
Figure1—CVDriskmarkersaccordingtofastingand2-hinsulinquartiles.DBP,diastolicbloodpressure;ICAM,intracellularadhesionmolecule-1;
SBP, systolic blood pressure.
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not associated with increased risk factors
for CVD.
With childhood obesity reaching ep-
idemic proportions, there is a need to
determine the best marker for early iden-
tiﬁcation of CVD morbidity in this popu-
lation. In our study, quartiles of glucose,
both fasting and at 2 h, were not associ-
atedwithheightenedriskfactorsforCVD.
These children had glucose levels that
were within normal range. It is arguable
that, in children, glucose levels may need
to be in the impaired fasting glucose or
impaired glucose tolerance range in order
to begin to observe a relationship with
CVD risk factors.
Insulin levels have also been de-
scribed to play a signiﬁcant role with re-
gard to risk for CVD. In our study,
increases in insulin quartiles, fasting and
at 2 h, were associated with increase in a
number of CVD risk factors. It has been
postulated that diabetes and CVD may
share an underlying cause, a theory
known as the “common soil” hypothesis
(13–14). Insulin resistance has been pro-
posed as central to both progression to
type 2 diabetes and CVD. Our data, al-
though cross-sectional, suggest that hy-
perinsulinemia may well be the ﬁrst and
earlier abnormality that presents in chil-
dren at risk. We could speculate that this
may lead to an increase in CVD risk fac-
tors and, with time, to glucose dysregula-
tion. Prospective studies are needed, and
interventions should be initiated early in
life in overweight at-risk youths.
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